Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorena Alonso

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Plos One|July 20, 2012
Molecular characterization of circulating tumor cells in human metastatic colorectal cancerJorge Barbazán, Lorena Alonso-Alconada, Laura Muinelo-Romay, et al.
Diagnostic Microbiology and Infectious Disease|October 23, 2021
Clinical evaluation of the Procleix SARS-CoV-2 assay, a sensitive, high-throughput test that runs on an automated systemSilvia Sauleda, Lourdes Palacios, Vanessa Brès, et al.
Cells|May 20, 2020
Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian CancerManuel Abreu, Pablo Cabezas-Sainz, Lorena Alonso-Alconada, et al.
International Journal of Molecular Sciences|June 14, 2017
Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation StudyYolanda Vidal Insua, Juan de la Cámara, Elena Brozos Vázquez, et al.
Journal of Cellular and Molecular Medicine|February 7, 2012
A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancerJorge Barbazán, María Vieito, Alicia Abalo, et al.
Oncotarget|April 24, 2018
ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancerLaura Devis, Elena Martinez-Garcia, Cristian P Moiola, et al.
Clinical & Experimental Metastasis|May 1, 2015
Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasionNúria Pedrola, Laura Devis, Marta Llauradó, et al.
Journal of Clinical Medicine|February 27, 2020
Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial CancerCarlos Casas-Arozamena, Eva Díaz, Cristian Pablo Moiola, et al.
International Journal of Cancer|September 16, 2014
Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancerLorena Alonso-Alconada, Maria Santacana, Pablo Garcia-Sanz, et al.
Gynecologic Oncology|April 2, 2021
M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patientsAntonio Gil-Moreno, Lorena Alonso-Alconada, Berta Díaz-Feijoo, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Plos One|July 20, 2012
Molecular characterization of circulating tumor cells in human metastatic colorectal cancerJorge Barbazán, Lorena Alonso-Alconada, Laura Muinelo-Romay, et al.
Diagnostic Microbiology and Infectious Disease|October 23, 2021
Clinical evaluation of the Procleix SARS-CoV-2 assay, a sensitive, high-throughput test that runs on an automated systemSilvia Sauleda, Lourdes Palacios, Vanessa Brès, et al.
Cells|May 20, 2020
Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian CancerManuel Abreu, Pablo Cabezas-Sainz, Lorena Alonso-Alconada, et al.
International Journal of Molecular Sciences|June 14, 2017
Predicting Outcome and Therapy Response in mCRC Patients Using an Indirect Method for CTCs Detection by a Multigene Expression Panel: A Multicentric Prospective Validation StudyYolanda Vidal Insua, Juan de la Cámara, Elena Brozos Vázquez, et al.
Journal of Cellular and Molecular Medicine|February 7, 2012
A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancerJorge Barbazán, María Vieito, Alicia Abalo, et al.
Oncotarget|April 24, 2018
ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancerLaura Devis, Elena Martinez-Garcia, Cristian P Moiola, et al.
Clinical & Experimental Metastasis|May 1, 2015
Nidogen 1 and Nuclear Protein 1: novel targets of ETV5 transcription factor involved in endometrial cancer invasionNúria Pedrola, Laura Devis, Marta Llauradó, et al.
Journal of Clinical Medicine|February 27, 2020
Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial CancerCarlos Casas-Arozamena, Eva Díaz, Cristian Pablo Moiola, et al.
International Journal of Cancer|September 16, 2014
Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancerLorena Alonso-Alconada, Maria Santacana, Pablo Garcia-Sanz, et al.
Gynecologic Oncology|April 2, 2021
M-TRAP: Safety and performance of metastatic tumor cell trap device in advanced ovarian cancer patientsAntonio Gil-Moreno, Lorena Alonso-Alconada, Berta Díaz-Feijoo, et al.
Pageof 4